Financials
Financial year 2025
APOTHEEK VANSCHOENWINKEL from Leuven, company number BE0873591502, closed financial year 2025 with a result of € 11,338 after tax. For that financial year APOTHEEK VANSCHOENWINKEL recorded a gross margin of € 19,324 and equity of € 108,067. Compared with financial year 2024, the result moved from € 6,161 to € 11,338. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.
€ 108,067
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 11,338
▲ 84% vs 2024
Profit after tax over the fiscal year.
€ 101,742
▼ 21% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 11,300 paid out
100 % of the profit went to the shareholders, mostly to MARMILAN (100 % of the shares). That is where the money ends up.
People and assets in 2025
€ 1,513
▼ 66% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 33
▼ 73% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 56,026
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,414
▼ 31% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 120,494 | € 68,535 | € 16,597 | € 19,324 | ▲ 16% |
| Profit after taxes | € 101,737 | € 42,071 | € 6,161 | € 11,338 | ▲ 84% |
| Equity | € 107,797 | € 107,869 | € 108,029 | € 108,067 | |
| Total debts | € 230,933 | € 250,091 | € 283,845 | € 258,175 | ▼ 9% |
| Cash | € 81,088 | € 81,707 | € 129,045 | € 101,742 | ▼ 21% |
| Retained profit | € 101,597 | € 101,669 | € 101,829 | € 101,867 | |
| Dividend | € 101,650 | € 42,000 | € 6,000 | € 11,300 | ▲ 88% |
| Bank debt | € 2,830 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 338,731 | € 357,960 | € 391,874 | € 366,242 | ▼ 7% |
| Employees (FTE) | 0.3 | 0.9 | - | - |
Key figures of APOTHEEK VANSCHOENWINKEL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK VANSCHOENWINKEL?
What happened at APOTHEEK VANSCHOENWINKEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 11,338 (▲ 84% vs 2024). Source: NBB ↗
- Marmilan BV became a director. NBB
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 101,737 profit in 2022 to € 11,338 profit in 2025.
Paid € 2,889 in corporate taxes since 2022.
Best year ever: 2022, with € 101,737 profit.
Paid out € 160,950 in dividends to the owners in total.
A new publication or filing at APOTHEEK VANSCHOENWINKEL? We notify you, reason included.
Follow APOTHEEK VANSCHOENWINKELDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MARMILAN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK VANSCHOENWINKELBehind APOTHEEK VANSCHOENWINKEL is Marmilan BV. The shares are held by MARMILAN (100%).
Directors
According to the 2025 annual accounts
Director · represented by Anne Vanschoenwinkel
since 2015
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Diestsestraat 129
3000 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Hosting
AMAZON-02 - Amazon.com, Inc., US
DNS
AWS Route 53
Website info
Features
Security
Network
Details
- Company number
- 0873.591.502
- VAT number
- BE 0873.591.502
- Registered office
- Diestsestraat 129, 3000 Leuven
- Names & denominations
- APOTHEEK VANSCHOENWINKEL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 April 2005
- Peppol
- Active · Active since 1 Nov 2025
- Contact
- apotheekvanschoenwinkel.be
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten
Vervaardiging van geneesmiddelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels